Serum CRP Is a Better Early Marker for Response to Infliximab Induction Therapy Than Fecal Calprotectin in Patients With Moderate to Severe Ulcerative Colitis

被引：0
|
作者：
Brandse, Johannan F.
Jansen, Jeroen M.
Baars, Paul A.
Lowenberg, M.
Ponsioen, Cyriel
van den Brink, Gijs R.
D'Haens, Geert R.
机构：
来源：
GASTROENTEROLOGY | 2014年 / 146卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
212
引用
收藏
页码：S55 / S56
页数：2
相关论文
共 50 条
  • [1] Serum CRP is a better early marker for response to infliximab induction therapy than fecal calprotectin in patients with moderate to severe ulcerative colitis
    Brandse, J. F.
    Jansen, J. M.
    Baars, P. A.
    Lowenberg, M.
    Ponsioen, C. Y.
    van den Brink, G. R.
    D'Haens, G.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S210 - S211
  • [2] The Pharmacokinetics of Infliximab Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis
    Brandse, Johannan F.
    van der Kleij, Desiree
    Wolbink, Gert-Jan
    Rigter, Irma M.
    Baars, Paul A.
    Lowenberg, M.
    Ponsioen, Cyriel
    Jansen, Jeroen M.
    van den Brink, Gijs R.
    Mathot, Ron A.
    D'Haens, Geert R.
    GASTROENTEROLOGY, 2014, 146 (05) : S134 - S134
  • [3] Induction and Maintenance Therapy With Infliximab for Children With Moderate to Severe Ulcerative Colitis
    Hyams, Jeffrey
    Damaraju, Lakshmi
    Blank, Marion
    Johanns, Jewel
    Guzzo, Cynthia
    Winter, Harland S.
    Kugathasan, Subra
    Cohen, Stanley
    Markowitz, James
    Escher, Johanna C.
    Veereman-Wauters, Gigi
    Crandall, Wallace
    Baldassano, Robert
    Griffiths, Anne
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (04) : 391 - U169
  • [4] Pharmacokinetic Features and Presence of Antidrug Antibodies Associate With Response to Infliximab Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis
    Brandse, Johannan F.
    Mathot, Ron A.
    van der Kleij, Desiree
    Rispens, Theo
    Ashruf, Yael
    Jansen, Jeroen M.
    Rietdijk, Svend
    Lowenberg, Mark
    Ponsioen, Cyriel Y.
    Singh, Sharat
    van den Brink, Gijs R.
    D'Haens, Geert R.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (02) : 251 - +
  • [5] Fecal Calprotectin Responses Following Induction Therapy With Vedolizumab in Moderate to Severe Ulcerative Colitis: A Post Hoc Analysis of GEMINI 1
    Reinisch, Walter
    Bressler, Brian
    Curtis, Rebecca
    Parikh, Asit
    Yang, Huyuan
    Rosario, Maria
    Roseth, Arne
    Danese, Silvio
    Feagan, Brian
    Sands, Bruce E.
    Ginsburg, Philip
    Dassopoulos, Themistocles
    Lewis, James
    Xu, Jing
    Wyant, Tim
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (04) : 803 - 810
  • [6] The usefulness of stool hemoglobin and fecal calprotectin for detecting moderate to severe ulcerative colitis
    Kim, Dong Ju
    Koo, Ja Seol
    Lee, Dong-Won
    Kim, Seung Young
    Jung, Sung Woo
    Choe, Jung Wan
    Seo, Ji Hye
    Sim, Ju Sung
    Lee, Ye Jin
    Lee, Sang Woo
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 177 - 177
  • [7] The value of fecal calprotectin as a marker of intestinal inflammation in patients with ulcerative colitis
    Onal, Ibrahim Koral
    Beyazit, Yavuz
    Sener, Burcin
    Savuk, Burak
    Etik, Digdem Ozer
    Sayilir, Abdurrahim
    Oztas, Erkin
    Torun, Serkan
    Ozin, Yasemin Ozderin
    Demirel, Bilge Tunc
    Ulker, Aysel
    Dagli, Ulku
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2012, 23 (05): : 509 - 514
  • [8] Consecutive Fecal Calprotectin Measurements to Predict Relapse in Patients with Ulcerative Colitis Receiving Infliximab Maintenance Therapy
    De Vos, Martine
    Louis, Edouard J.
    Jahnsen, Jorgen
    Vandervoort, Jo G. P.
    Noman, Maja
    Dewit, Olivier
    D'Haens, Geert R.
    Franchimont, Denis
    Baert, Filip J.
    Torp, Roald A.
    Henriksen, Magne
    Potvin, Philippe M. R.
    Van Hootegem, Philippe P.
    Hindryckx, Pieter M.
    Moreels, Tom G.
    Collard, Arnaud
    Karlsen, Lars Normann
    Kittang, Eirik
    Lambrecht, Guy
    Grimstad, Tore
    Koch, Jonas
    Lygren, Idar
    Coche, Jean-Claude R. J.
    Mana, Fazia
    Van Gossum, Andre
    Belaiche, Jacques
    Cool, Mike R.
    Fontaine, Fernand
    Maisin, Jean-Marc G.
    Muls, Vinciane
    Neuville, Bart
    Staessen, Dirk A. J.
    Van Assche, Gert A.
    de Lange, Thomas
    Solberg, Inger Camilla
    Vander Cruyssen, Bert J. K.
    Vermeire, Severine A. R. A.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (10) : 2111 - 2117
  • [9] Induction and maintenance infliximab therapy in children with moderate to severe ulcerative colitis: Retrospective, multicenter study
    Iwanczak, Barbara M.
    Kierkus, Jaroslaw
    Ryzko, Jozef
    Szczepanik, Mariusz
    Wiecek, Sabina
    Czaja-Bulsa, Grazyna
    Kacperska, Magdalena
    Korczowski, Bartosz
    Maslana, Jolanta
    Iwanczak, Franciszek
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 26 (01): : 57 - 61
  • [10] Usefulness of Fecal Calprotetin in Detecting the Early Response to Induction Therapy in Ulcerative Colitis
    Kobayashi, Taku
    Toyonaga, Takahiko
    Nakano, Masaru
    Saito, Eiko
    Okabayashi, Shinji
    Ozaki, Ryo
    Kuronuma, Satoshi
    Tablante, Maria Carla
    Takeuchi, Osamu
    Hibi, Toshifumi
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S330 - S330
12345